BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32920959)

  • 1. Brodalumab in the treatment of recalcitrant acrodermatitis continua of Hallopeau.
    Bardazzi F; Di Altobrando A; Lacava R
    Dermatol Ther; 2020 Nov; 33(6):e14301. PubMed ID: 32920959
    [No Abstract]   [Full Text] [Related]  

  • 2. Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report.
    Battista T; Guerrasio G; De Fata Salvatores G; Peduto T; Fabbrocini G; Di Guida A
    Dermatol Ther; 2022 May; 35(5):e15383. PubMed ID: 35174591
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of acrodermatitis continua of Hallopeau evolving into generalized pustular psoriasis successfully treated with guselkumab.
    Yamamoto H; Kamiya K; Okada H; Maekawa T; Komine M; Ohtsuki M
    Int J Dermatol; 2023 Feb; 62(2):269-270. PubMed ID: 35187654
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of acrodermatitis continua of Hallopeau successfully treated with guselkumab.
    Buononato D; Licata G; Gambardella A; De Rosa A; Calabrese G; Argenziano G
    Dermatol Ther; 2022 Jul; 35(7):e15514. PubMed ID: 35420733
    [No Abstract]   [Full Text] [Related]  

  • 5. Etanercept for pediatric acrodermatitis continua of Hallopeau: A case report and literature review.
    Ruggiero A; Patruno C; Napolitano M; Megna M; Gisonni P; Cirillo T; Fabbrocini G
    Dermatol Ther; 2020 Nov; 33(6):e14046. PubMed ID: 32700773
    [No Abstract]   [Full Text] [Related]  

  • 6. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
    Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab treatment for acrodermatitis continua of Hallopeau: three cases refractory to IL-17 inhibition.
    Zhang Z; Wu X; Han C; Chen M; Liu Y
    J Dtsch Dermatol Ges; 2023 Jul; 21(7):785-787. PubMed ID: 37186059
    [No Abstract]   [Full Text] [Related]  

  • 8. Acrodermatitis continua Hallopeau successfully treated by risankizumab.
    Hugo J; Gkalpakioti P; Arenbergerova M; Arenberger P; Gkalpakiotis S
    Int J Dermatol; 2021 Apr; 60(4):e144-e145. PubMed ID: 33368238
    [No Abstract]   [Full Text] [Related]  

  • 9. [Impetigo herpetiformis; acrodermatitis continua of Hallopeau and pustular psoriasis; etiology and pathogenesis and differential diagnosis].
    GRANELLI U
    Minerva Dermatol; 1956 Apr; 31(4):120-6. PubMed ID: 13348185
    [No Abstract]   [Full Text] [Related]  

  • 10. Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option?
    Megna M; Potestio L; Di Caprio N; Tajani A; Fabbrocini G; Annunziata A
    Dermatol Ther; 2022 May; 35(5):e15423. PubMed ID: 35261135
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful therapy of acrodermatitis continua of Hallopeau with IL-23 blockers -two new cases.
    Langer N; Wilsmann-Theis D; Kromer C; Mohr J; Mössner R
    J Dtsch Dermatol Ges; 2021 Oct; 19(10):1504-1507. PubMed ID: 34581001
    [No Abstract]   [Full Text] [Related]  

  • 12. Acrodermatitis continua of Hallopeau in an elderly patient successfully and rapidly treated with risankizumab: a case report.
    Orsini D; Iacovelli P; Frascione P; Pacifico A
    J Dermatolog Treat; 2023 Dec; 34(1):2229468. PubMed ID: 37381703
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Recalcitrant Acrodermatitis Continua of Hallopeau With Brodalumab.
    Milani-Nejad N; Kaffenberger J
    J Drugs Dermatol; 2019 Oct; 18(10):1047. PubMed ID: 31603633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet.
    Pearson LH; Allen BS; Smith JG
    J Am Acad Dermatol; 1984 Oct; 11(4 Pt 2):755-62. PubMed ID: 6491002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acrodermatitis continua of Hallopeau: historical perspectives and modern management.
    Bhate C; Schwartz RA
    Ital J Dermatol Venerol; 2022 Apr; 157(2):132-136. PubMed ID: 35391533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acrodermatitis continua of Hallopeau: was it an outcome of a surgical trauma or initially misdiagnosed as onychomycosis?
    Sahin MT; Oztürkcan S; Türel A; Kandiloğlu AR
    J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):236-8. PubMed ID: 12705767
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of pediatric acrodermatitis continua of Hallopeau successfully treated with adalimumab biosimilar.
    Megna M; Fabbrocini G; Costa C; Ferrillo M
    Dermatol Ther; 2020 May; 33(3):e13327. PubMed ID: 32220123
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of brodalumab in acrodermatitis continua of Hallopeau: A case report.
    Passante M; Dastoli S; Nisticò SP; Bennardo L; Patruno C
    Dermatol Ther; 2020 Jan; 33(1):e13170. PubMed ID: 31762153
    [No Abstract]   [Full Text] [Related]  

  • 19. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
    Galluzzo M; D'Adamio S; Teoli M; Bianchi L; Talamonti M
    Dermatol Ther; 2019 May; 32(3):e12899. PubMed ID: 30969010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acrodermatitis continua of hallopeau with ixekizumab.
    Miller AC; Holland TE; Cohen DJ
    J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.